Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALAB vs MRNA✓SelectedUSD · MRNAALAB vs MRNA performance historyLatest closeAs of-8.79%11/16
Stock and ETF performance explorer

ALAB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.1%
MRNA return
+778.7%
Excess return
-735.5%
Maximum drawdown
-62.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.8%-3.6%-5.2%-8.7%
7D-6.7%-20.0%+13.3%-6.3%
30D-29.2%-1.3%-28.0%-29.1%
3M-37.1%+240.0%-277.1%-37.5%
6M-13.0%+339.0%-352.0%-20.2%
YTD+21.6%+630.0%-608.3%-10.0%
All+43.1%+778.7%-735.5%-0.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling